NO902084L - Fremgangsmaate for fremstilling av substituerte pyrrolforbindelser. - Google Patents

Fremgangsmaate for fremstilling av substituerte pyrrolforbindelser.

Info

Publication number
NO902084L
NO902084L NO90902084A NO902084A NO902084L NO 902084 L NO902084 L NO 902084L NO 90902084 A NO90902084 A NO 90902084A NO 902084 A NO902084 A NO 902084A NO 902084 L NO902084 L NO 902084L
Authority
NO
Norway
Prior art keywords
role
compounds
procedure
preparing substituted
pyrol
Prior art date
Application number
NO90902084A
Other languages
English (en)
Other versions
NO902084D0 (no
NO174892B (no
NO174892C (no
Inventor
Gerd Dannhardt
Ludwig Steindl
Matthias Lehr
Original Assignee
Gerd Dannhardt
Merckle Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gerd Dannhardt, Merckle Gmbh filed Critical Gerd Dannhardt
Publication of NO902084D0 publication Critical patent/NO902084D0/no
Publication of NO902084L publication Critical patent/NO902084L/no
Publication of NO174892B publication Critical patent/NO174892B/no
Publication of NO174892C publication Critical patent/NO174892C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/323—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to the ring nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/33—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/337—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Rheumatology (AREA)
  • Hematology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyrrole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO902084A 1989-05-11 1990-05-10 Analogifremgangsmåte for fremstilling av terapeutisk aktive, substituerte dihydropyrrolizinforbindelser NO174892C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3915450A DE3915450A1 (de) 1989-05-11 1989-05-11 Substituierte pyrrolverbindungen und deren anwendung in der pharmazie

Publications (4)

Publication Number Publication Date
NO902084D0 NO902084D0 (no) 1990-05-10
NO902084L true NO902084L (no) 1990-11-12
NO174892B NO174892B (no) 1994-04-18
NO174892C NO174892C (no) 1994-07-27

Family

ID=6380477

Family Applications (1)

Application Number Title Priority Date Filing Date
NO902084A NO174892C (no) 1989-05-11 1990-05-10 Analogifremgangsmåte for fremstilling av terapeutisk aktive, substituerte dihydropyrrolizinforbindelser

Country Status (13)

Country Link
EP (1) EP0397175B1 (no)
JP (1) JP2796876B2 (no)
KR (1) KR0173455B1 (no)
AR (1) AR246256A1 (no)
AT (1) ATE98246T1 (no)
AU (1) AU637098B2 (no)
CA (1) CA2016501C (no)
DD (1) DD294260A5 (no)
DE (2) DE3915450A1 (no)
DK (1) DK0397175T3 (no)
ES (1) ES2062160T3 (no)
FI (1) FI95258C (no)
NO (1) NO174892C (no)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6492413B2 (en) 1993-01-15 2002-12-10 G.D. Searle & Co. 3.4-diaryl thiophenes and analogs thereof having use as antiinflammatory agents
AU6027694A (en) * 1993-01-15 1994-08-15 G.D. Searle & Co. Novel 3,4-diaryl thiophenes and analogs thereof having use as antiinflammatory agents
US5474995A (en) * 1993-06-24 1995-12-12 Merck Frosst Canada, Inc. Phenyl heterocycles as cox-2 inhibitors
DE4338770A1 (de) * 1993-11-12 1995-05-18 Matthias Dr Lehr Indol-2-alkansäuren und ihre Derivate als Hemmstoffe der Phospholipase A¶2¶
DE4419247A1 (de) * 1994-06-01 1995-12-07 Merckle Gmbh Sulfonylierte Pyrrolizincarbonsäureamide und deren Anwendung in der Pharmazie
DE4419246A1 (de) * 1994-06-01 1995-12-07 Merckle Gmbh Heteroarylsubstituierte Pyrrolizinverbindungen und deren Anwendung in der Pharmazie
DE4419315A1 (de) * 1994-06-01 1995-12-07 Merckle Gmbh Heteropyrrolizinverbindungen und deren Anwendung in der Pharmazie
CA2262847C (en) * 1996-08-01 2007-06-05 Merckle Gmbh Acylpyrroldicarboxylic acids and acylindoldicarboxylic acids and their derivatives and inhibitors of the cytosolic phospholipase a2
DE10001166A1 (de) * 2000-01-13 2001-07-19 Merckle Gmbh Anellierte Pyrrolverbindungen, diese enthaltende pharmazeutische Mittel und deren Verwendung
DE50101761D1 (de) * 2000-01-28 2004-04-29 Merckle Gmbh Verfahren zur herstellung von 6-(4-chlorphenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1h-pyrrolizin-5-yl-essigsäure
DE10004157A1 (de) * 2000-02-01 2001-08-02 Merckle Gmbh Chem Pharm Fabrik 4-Pyridyl-und 2,4-Pyrimidinyl-substituierte Pyrrolderivate und ihre Anwendung in der Pharmazie
KR20020007836A (ko) * 2000-07-19 2002-01-29 신덕호 골프공
DE10141285A1 (de) 2001-08-23 2003-03-27 Merckle Gmbh Verfahren zur Herstellung von 6-(4-Chlorphenyl)-2,2-dimethyl-7-phnyl-2,3-dihydro-1H-pyrrolizin-5-yl-essigsäure
DE102005012971A1 (de) * 2005-03-21 2006-09-28 Merckle Gmbh Polymorphe Form von 6-(4-Chlorphenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1H-pyrrolizin-5-yl-essigsäure

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1156488A (en) * 1965-04-30 1969-06-25 Firmenich & Cie Phenolic Flavouring Agents
AU429651B2 (en) * 1968-08-08 1972-11-01 Commonwealth Scientific And Industrial Research Organization Antiviral 6, 7 dihydro 5h pyrrolizines and related compounds
DE2062984A1 (en) * 1970-12-21 1972-06-22 Messerschmitt, Thilo, 8094 Reitmehring; Dobeneck, Henning von, 8021 Icking 2-unsubstd-5-formyl-pyrrole prepn - by catalytic hydrogenation of 2-halo-5-formyl-pyrroles
DE2261965A1 (de) * 1971-12-23 1973-06-28 Continental Pharma Derivate der pyrrolessigsaeure und deren salze sowie von pyrrolacetonitril, verfahren zur herstellung dieser verbindungen, diese verbindungen enthaltende pharmazeutische produkte und verwendung dieser verbindungen und produkte
JPS5217074B2 (no) * 1972-04-25 1977-05-13
JPS6011899B2 (ja) * 1978-12-27 1985-03-28 財団法人相模中央化学研究所 ピロ−ル酢酸誘導体の製造方法
JPS5687558A (en) * 1979-11-27 1981-07-16 Mcneilab Inc Manufacture of pyrrolee22acetic acids
US4284562A (en) * 1979-11-27 1981-08-18 Mcneilab, Inc. Process for preparing pyrrole-2-acetic acids
JPS56100784A (en) * 1980-01-16 1981-08-12 Yoshitomi Pharmaceut Ind Ltd Indolizine derivative
US4327221A (en) * 1980-10-15 1982-04-27 American Home Products Corporation 2-Substituted-3-hydroxythiazolo(2,3-8)-thiazolium salts and mesoionic didehydro derivatives thereof
JPS57501964A (no) * 1980-12-15 1982-11-04
DE3368416D1 (en) * 1982-02-25 1987-01-29 Beecham Group Plc Aroyl pyrrolizine compounds, process for their preparation and pharmaceutical compositions containing them
FR2539417A1 (fr) * 1983-01-13 1984-07-20 Rhone Poulenc Sante Nouveaux pyrrolo-1, 2 heterocycles, leur preparation et les medicaments qui les contiennent
FR2557111B1 (fr) * 1983-12-21 1986-04-11 Rhone Poulenc Sante Nouveaux derives ortho-condenses du pyrrole, leur preparation et les medicaments qui les contiennent
IL78834A (en) * 1985-05-23 1992-07-15 Smithkline Beckman Corp 2,3-dihydro-5-(1,4-dihydropyridin-4-yl)-6-phenylimidazo(2,1-b)thiazoles and 6,7-dihydro-3-(1,4-dihydropyridin-4-yl)-2-phenyl-5h-imidazo(2,1-b)(1,3)thiazines and their use as intermediates in a process for preparing the corresponding pyridyl-substituted imidazo(2,1-b)thiazoles and 5h-imidazo(2,1-b)(1,3)thiazines
FR2601016B1 (fr) * 1986-07-04 1988-10-07 Rhone Poulenc Sante Nouveaux derives du 1h,3h-pyrrolo (1,2-c) thiazole, leur preparation et les compositions pharmaceutiques qui les contiennent
FR2617484B1 (fr) * 1987-07-02 1989-10-20 Rhone Poulenc Sante Procede de preparation de l'acide (pyridyl-3)-3 1h-3h-pyrrolo (1,2-c) thiazolecarboxylique-7 dextrogyre

Also Published As

Publication number Publication date
DE3915450A1 (de) 1990-11-15
NO902084D0 (no) 1990-05-10
DD294260A5 (de) 1991-09-26
FI95258B (fi) 1995-09-29
ES2062160T3 (es) 1994-12-16
KR0173455B1 (ko) 1999-02-01
KR900018103A (ko) 1990-12-20
FI902316A0 (fi) 1990-05-09
JP2796876B2 (ja) 1998-09-10
EP0397175A1 (de) 1990-11-14
DK0397175T3 (da) 1994-02-14
AR246256A1 (es) 1994-07-29
NO174892B (no) 1994-04-18
EP0397175B1 (de) 1993-12-08
JPH035455A (ja) 1991-01-11
FI95258C (fi) 1996-01-10
AU637098B2 (en) 1993-05-20
ATE98246T1 (de) 1993-12-15
CA2016501C (en) 2001-10-09
DE59003753D1 (de) 1994-01-20
AU5480090A (en) 1990-11-15
NO174892C (no) 1994-07-27
CA2016501A1 (en) 1990-11-11

Similar Documents

Publication Publication Date Title
NO903656D0 (no) Fremgangsmaate for fremstilling av 17beta-acyl-4-aza-5alfa-androst-1-en-3-oner.
NO903190L (no) Fremgangsmaate for klorering av sukrose-b-estere.
NO900831D0 (no) Fremgangsmaate for fremstilling av piperidinforbindelser.
NO904839D0 (no) Fremgangsmaate for fremstilling av benzoxazinderivater.
NO913745D0 (no) Fremgangsmaate for fremstilling av 1,3-benzoksazinderivater
NO902084D0 (no) Fremgangsmaate for fremstilling av substituerte pyrrolforbindelser.
NO901070D0 (no) Fremgangsmaate for fremstilling av tieno-triazolo-diazepin-derivater.
NO901832L (no) Fremgangsmaate for fremstilling av polyketon.
NO903780D0 (no) Fremgangsmaate til fremstilling av epipodofyllotoksinaltrosid-derivater.
NO904222D0 (no) Fremgangsmaate for fremstilling av benzodiazepiner.
FI902336A0 (fi) Anordning foer framstaellning av en fristaoende kiselkristall.
NO911368D0 (no) Fremgangsmaate for fremstilling av 2-substituerte alkyl-3-karboksy-karbapenemer.
NO901071L (no) Fremgangsmaate for fremstilling av tieno-triazolo-diazepin-derivater.
NO883339D0 (no) Fremgangsmaate for fremstilling av benzimidazol-2-yl-pyridiniumforbindelser.
NO903666L (no) Fremgangsmaate for fremstilling av pyrrolokinolinforbindelser.
NO164238C (no) Fremgangsmaate for fremstilling av pyridobenzodiazepinforbindelser.
NO904034D0 (no) Fremgangsmaate for fremstilling av 1-etylfenoksatiin-10,10-dioksyd.
NO910556L (no) Fremgangsmaate for fremstilling av 7-amino-3-metoksymetyl-cef-3-em-4-karboksylsyre.
NO903196D0 (no) Fremgangsmaate for fremstilling av 2-diazo-3-trisubstituerte silyloksy-3-butenoater.
NO901834D0 (no) Fremgangsmaate for fremstilling av polycykliske forbindelser.
NO875403D0 (no) Fremgangsmaate ved fremstilling av poelse.
NO170578C (no) Fremgangsmaate for fremstilling n,n-dimetylaminometylarylforbindelser
NO912828D0 (no) Fremgangsmaate ved fremstilling av cellulosemasse.
NO894792L (no) Fremgangsmaate for fremstilling av sandaggregater.
NO892935L (no) Fremgangsmaate for fremstilling av kinolinforbindelser.

Legal Events

Date Code Title Description
MK1K Patent expired